Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Colorectal Cancer | Research

Patient navigation for colorectal cancer screening in deprived areas: the COLONAV cluster randomized controlled trial

Authors: A. Bourmaud, Y. Benoist, F. Tinquaut, C. Allary, J. Ramone-Louis, M. Oriol, J. Kalecinski, V. Dutertre, N. Lechopier, M. Pommier, S. Rousseau, A. Dumas, P. Amiel, V. Regnier, V. Buthion, F. Chauvin

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

The objective of this study was to assess the effectiveness of a Patient Navigation Intervention targeting deprived patients for Colo-Rectal Cancer (CRC) screening participation.

Methods

A cluster randomized controlled trial was conducted in 5 districts. Peer Lay Patient Navigators were recruited to operate in deprived areas. Eligible participants had to be between 50 and 74 years old, live in these deprived areas and receive an invitation to the nationally organized Colo-Rectal Cancer (CRC) screening during the study period. The theory-driven navigation intervention was deployed for 18 months. A population Health Intervention Research assessment method was used to assess effectiveness and context interaction. The primary criterion was screening participation at 12 months.

Results

Twenty-four thousand two hundred eighty-one individuals were included inside 40 clusters. The increase in participation in the intervention group was estimated at 23%, (ORa = 1.23, CI95% [1.07–1.41], p = 0.003). For the subgroup of individuals who participated, the time delay to participating was reduced by 26% (ORa = 0.74, CI95% [0.57–0.96], p = 0.021). Main factors modulating the effect of the intervention were: closeness of navigator profiles to the targeted population, navigators’ abilities to adapt their modus operandi, and facilitating attachment structure.

Conclusion

The ColoNav Intervention succeeded in demonstrating its effectiveness, for CRC screening. Patient Navigation should be disseminate with broader health promotion goals in order to achieve equity in health care.

Trial registration

clinicaltrials.gov NCT02369757 24/02/2015.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRef Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRef
2.
go back to reference Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.CrossRef Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.CrossRef
3.
go back to reference Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.CrossRef Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–64.CrossRef
4.
go back to reference Cunningham D, Atkin W, Lenz H-J, et al. Colorectal cancer. Lancet Lond Engl. 2010;375(9719):1030–47.CrossRef Cunningham D, Atkin W, Lenz H-J, et al. Colorectal cancer. Lancet Lond Engl. 2010;375(9719):1030–47.CrossRef
5.
go back to reference PDQ Screening and Prevention Editorial Board. Colorectal Cancer Screening (PDQ®): Health Professional Version. 2022 Apr 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389266. PDQ Screening and Prevention Editorial Board. Colorectal Cancer Screening (PDQ®): Health Professional Version. 2022 Apr 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389266.
6.
go back to reference Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.CrossRef Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.CrossRef
7.
go back to reference European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51–9. European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51–9.
8.
go back to reference Essink-Bot M-L, Dekker E. Equal access to colorectal cancer screening. The Lancet. 2016;387(10020):724–6.CrossRef Essink-Bot M-L, Dekker E. Equal access to colorectal cancer screening. The Lancet. 2016;387(10020):724–6.CrossRef
10.
go back to reference Clarke N, McNamara D, Kearney PM, et al. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening. Prev Med. 2016;93:198–203.CrossRef Clarke N, McNamara D, Kearney PM, et al. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening. Prev Med. 2016;93:198–203.CrossRef
11.
go back to reference Pornet C, Dejardin O, Morlais F, et al. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol. Community Health. 2010;64(4):318–24. Pornet C, Dejardin O, Morlais F, et al. Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol. Community Health. 2010;64(4):318–24.
12.
go back to reference Mackenbach JP, Stirbu I, Roskam A-JR et al. Socioeconomic inequalities in health in 22 European countries. N. Engl. J. Med. 2008; 358(23):2468–2481. Mackenbach JP, Stirbu I, Roskam A-JR et al. Socioeconomic inequalities in health in 22 European countries. N. Engl. J. Med. 2008; 358(23):2468–2481.
13.
go back to reference Menvielle G, Kunst AE, Stirbu I, et al. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br J Cancer. 2008;98(5):1012–9.CrossRef Menvielle G, Kunst AE, Stirbu I, et al. Educational differences in cancer mortality among women and men: a gender pattern that differs across Europe. Br J Cancer. 2008;98(5):1012–9.CrossRef
14.
go back to reference Kobayashi LC, Wardle J, von Wagner C. Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing. Prev Med. 2014;61:100–5.CrossRef Kobayashi LC, Wardle J, von Wagner C. Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing. Prev Med. 2014;61:100–5.CrossRef
15.
go back to reference Wools A, Dapper EA, de Leeuw JRJ. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26(1):158–68.CrossRef Wools A, Dapper EA, de Leeuw JRJ. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26(1):158–68.CrossRef
16.
go back to reference Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317–24.CrossRef Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008;168(12):1317–24.CrossRef
17.
go back to reference Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRef Percac-Lima S, Grant RW, Green AR, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRef
18.
go back to reference Sunny A, Rustveld L. The Role of Patient Navigation on Colorectal Cancer Screening Completion and Education: a Review of the Literature. J Cancer Educ. 2018;33(2):251–9.CrossRef Sunny A, Rustveld L. The Role of Patient Navigation on Colorectal Cancer Screening Completion and Education: a Review of the Literature. J Cancer Educ. 2018;33(2):251–9.CrossRef
19.
go back to reference Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.CrossRef Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.CrossRef
20.
go back to reference Allary C, Bourmaud A, Tinquaut F, et al. ColoNav: patient navigation for colorectal cancer screening in deprived areas - Study protocol. BMC Cancer. 2016;16:416.CrossRef Allary C, Bourmaud A, Tinquaut F, et al. ColoNav: patient navigation for colorectal cancer screening in deprived areas - Study protocol. BMC Cancer. 2016;16:416.CrossRef
22.
go back to reference Bonell C, Fletcher A, Morton M, et al. Realist randomised controlled trials: a new approach to evaluating complex public health interventions Soc. Sci Med. 2012;75(12):2299–306.CrossRef Bonell C, Fletcher A, Morton M, et al. Realist randomised controlled trials: a new approach to evaluating complex public health interventions Soc. Sci Med. 2012;75(12):2299–306.CrossRef
23.
go back to reference Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.CrossRef Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015;350:h1258.CrossRef
24.
go back to reference Fletcher A, Jamal F, Moore G, et al. Realist complex intervention science: Applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions. Evaluation (Lond). 2016;22(3):286–303.CrossRef Fletcher A, Jamal F, Moore G, et al. Realist complex intervention science: Applying realist principles across all phases of the Medical Research Council framework for developing and evaluating complex interventions. Evaluation (Lond). 2016;22(3):286–303.CrossRef
25.
go back to reference Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005;43(6):551–7.CrossRef Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005;43(6):551–7.CrossRef
26.
go back to reference Fiscella K, Ransom S, Jean-Pierre P, et al. Patient-reported outcome measures suitable to assessment of patient navigation. Cancer. 2011;117(15 Suppl):3603–17. Fiscella K, Ransom S, Jean-Pierre P, et al. Patient-reported outcome measures suitable to assessment of patient navigation. Cancer. 2011;117(15 Suppl):3603–17.
27.
go back to reference Lvi-Strauss C. The savage mind, University of Chicago Press, 1966. Lvi-Strauss C. The savage mind, University of Chicago Press, 1966.
28.
go back to reference Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(12):1645–58.CrossRef Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(12):1645–58.CrossRef
29.
go back to reference Guillaume E, Dejardin O, Bouvier V, et al. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Prev Med. 2017;103:76–83.CrossRef Guillaume E, Dejardin O, Bouvier V, et al. Patient navigation to reduce social inequalities in colorectal cancer screening participation: A cluster randomized controlled trial. Prev Med. 2017;103:76–83.CrossRef
Metadata
Title
Patient navigation for colorectal cancer screening in deprived areas: the COLONAV cluster randomized controlled trial
Authors
A. Bourmaud
Y. Benoist
F. Tinquaut
C. Allary
J. Ramone-Louis
M. Oriol
J. Kalecinski
V. Dutertre
N. Lechopier
M. Pommier
S. Rousseau
A. Dumas
P. Amiel
V. Regnier
V. Buthion
F. Chauvin
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-022-10169-3

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine